Form 4: Surmodics Inc. Executive Charles W. Olson Reports Stock Transaction

Surmodics Inc. SVP, Medical Device Coatings, Charles W. Olson, reports the disposal of 1,534 shares of common stock to cover tax obligations.

Summary

• Charles W. Olson, SVP of Medical Device Coatings at Surmodics Inc., filed a Form 4 indicating a transaction involving the company's common stock.
• On November 30, 2024, Mr. Olson disposed of 1,534 shares of common stock at a price of $39.45 per share.
• This transaction was to cover tax obligations related to vesting of restricted stock.
• Following the transaction, Mr. Olson directly owns 52,437 shares of Surmodics common stock.
• He also indirectly owns 800 shares through an IRA.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing of an insider transaction, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It does not indicate any specific trend in the medical device industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, and this transaction is consistent with typical executive stock transactions.
• The sale of shares to cover tax obligations is a common occurrence among executives who receive stock-based compensation.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a small sale by an executive.

Key Dates

Keywords

Surmodics, SRDX, Form 4, insider trading, stock transaction, executive, Charles W. Olson, medical device coatings, share disposal